TransMedics, Inc., founded in 1998, is a medical device and logistics company focused on organ transplantation. The firm develops technology and provides clinical expertise aimed at increasing the number of donor organs available for transplant. It addresses a significant gap in the field: roughly 20% of viable donor organs are discarded due to limitations in traditional cold-storage methods.
The company's core product is the Organ Care System (OCS™), the only FDA-approved portable technology for heart, lung, and liver transplantation. The system keeps donor organs alive, perfused, and functioning during transport, which allows for real-time viability assessment. This approach extends the viable transport window and increases utilization of organs that might otherwise go unused. TransMedics operates a dedicated air logistics network and runs the National OCS Program, which provides 24/7 clinical support for transplant teams across the United States.
TransMedics works across the transplantation, healthcare, and medical device sectors. Its technical domains include organ preservation technology, perfusion systems, and medical device logistics. The company's stated mission centers on saving lives through innovation in organ preservation and transport.
